SCHEMBL2637889

SCHEMBL2637889

COc1ccccc1C(=O)Nc1c(=O)[nH]n2c(=O)cc(-c3ccc(Cl)cc3)[nH]c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.46
ALDH1A1 P00352 4/20 0.46
MAPT P10636 3/20 0.46
GLA P06280 1/20 0.46
KDM4E B2RXH2 2/20 0.45
KCNMA1 Q12791 1/20 0.45
HIF1A Q16665 1/20 0.45
LMNA P02545 2/20 0.43
PNLIP P16233 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
HPGD P15428 1/20 0.42
TACR3 P29371 1/20 0.41
GRM5 P41594 1/20 0.41
KCNK3 O14649 1/20 0.41
KCNK9 Q9NPC2 1/20 0.41
RXFP1 Q9HBX9 2/20 0.40
BRD4 O60885 1/20 0.40
BRPF1 P55201 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2637331 0.91 KMT2A (0.47) KMT2AALDH1A1MAPTGLAKDM4E
SCHEMBL2637499 0.91 KMT2A (0.44) KMT2AALDH1A1MAPTGLAKDM4E
SCHEMBL2637595 0.85 MAPT (0.43) KMT2AMAPTKCNMA1LMNAPNLIP
SCHEMBL2637556 0.83 POLB (0.46) KMT2AALDH1A1MAPTKDM4ELMNA
SCHEMBL2637406 0.78 MAPT (0.41) KMT2AALDH1A1MAPTKDM4EKCNMA1
SCHEMBL2637547 0.77 NPC1 (0.48) KMT2AMAPTLMNANPC1RAB9A
SCHEMBL2638375 0.76 MAPT (0.48) KMT2AALDH1A1MAPTKCNMA1LMNA
SCHEMBL2637343 0.75 ALDH1A1 (0.46) KMT2AALDH1A1MAPTNPC1RAB9A
SCHEMBL2637590 0.74 KDM4E (0.41) KMT2AALDH1A1MAPTKDM4ELMNA
SCHEMBL2637478 0.73 HSP90AA1 (0.47) KMT2AALDH1A1MAPTLMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2438070-A1 GLYCINE B ANTAGONISTS Merz Pharma GmbH & Co. KGaA (DE) 2012-04-11 EP disclosed
WO-2010139483-A1 GLYCINE B ANTAGONISTS MERZ PHARMA GMBH & CO. KGAA (DE) 2010-12-09 WO disclosed